BackKinnate Biopharma Overview

Kinnate Biopharma Cost of Revenue

Cost of Revenue analysis for KNTE.

Quarterly Cost of Revenue

$198000.00
↑ 4.21% YoY

As of Dec 31, 2023

Annual Cost of Revenue (TTM)

$799000.00
↑ 46.34% YoY

Trailing 12 months ending Dec 31, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin